|
|||||
|
|
Phosphatidylinositol 3-kinase pathway genomic alterations in 60,991 diverse solid tumors informs targeted therapy opportunities |
|
| Authors: | Sherri Z. Millis PhD Denis L. Jardim MD PhD Lee Albacker PhD Jeffrey S. Ross MD Vincent A. Miller MD Siraj M. Ali MD PhD Razelle Kurzrock MD |
| Affiliation: | 1. Department of Clinical Oncology, Hospital Sírio Libanes, Sao Paulo, Brazil;2. Foundation Medicine, Cambridge, Massachusetts;3. Center for Personalized Cancer Therapy and Division of Hematology and Oncology, University of California San Diego, San Diego, California |
| Abstract: | |
| Keywords: | cancer genome molecular profile phosphoinositide 3-kinase catalytic subunit α (PIK3CA) precision oncology targeted therapy |